Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics
Volker Wacheck(Medical University of Vienna), Richard F. Schlenk(University Hospital Ulm)
Cited by 5